Superantigens of mouse mammary tumour virus: Implications for diabetes?

Diabetes/Metabolism Reviews

Volumn 12, Issue 2, 1996, Pages 111-119

  Acha Orbea, Hans ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AUTOIMMUNITY; DIABETES MELLITUS; IMMUNE RESPONSE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; MAMMARY TUMOR VIRUS, MOUSE; MICE; SUPERANTIGENS;

EID: 0029740869     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199607)12:2<111::AID-DMR158>3.0.CO;2-O     Document Type: Review

References (59)

1. Kappler JW, Roehm N, and Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280, 1987.
2. Kappler JW, Wade T, White J, Kushnir W, Blackman M, Bill J, Roehm N, and Marrack P: A T cell receptor Vβ segment that imparts reactivity to a class II major histocompatibility complex product. Cell 49: 263-271, 1987.
3. Fleischer B, and Schrezenmeier H: T cell stimulation by staphylococcal enterotoxins: clonally variable response and requirements for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med 167: 1697-1707, 1988.
4. a-encoded antigens. Nature 332: 40-45, 1988.
5. Kappler JW, Staerz UD, White J, and Marrack PC: Self-tolerance eliminats T cells specific for Mls-modified products of the major histocompatibility complex. Nature 332: 35-40, 1988.
6. Janeway CA, Yagi J, Conrad PJ, Katz ME, Jones B, Vroegop S, and Buxser S. T-cell responses to Mis and to bacterial proteins that mimic its behaviour. Immunol Rev 107: 61-88, 1989.
7. White J, Herman A, Pullen AM, Kubo R, Kappler JW, and Marrack P: The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 27-35, 1989.
8. Mollick JA, Cook G, and Rich RR: Class II MHC molecules are specific receptors for staphylococcal enterotoxins. Science 244: 817-820, 1989.
9. Fraser JD: High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 339: 221-223, 1989.
10. Herrmann T, Accolla RS, and MacDonald HR: Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.. Eur J Immunol 19: 2171-2174, 1989.
11. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuiller F, Charron D, Lotteau V, and Scott-Algara D: Evidence for a viral superantigen in humans. Nature 358: 507-510, 1992.
12. Acha-Orbea H, and MacDonald HR: Superantigens of mouse mammary tumor virus. Annu Rev Immunol 13: 459-486, 1995.
13. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, and Wiley DC: Three-dimensional structure of a human class II histocompatibility complexed with superantigen. Nature 368: 711-71, 1994.
14. Acha-Orbea H: Bacterial and viral superantigens: roles in autoimmunity? Ann Rheum Dis 52: S6-S16, 1993.
15. Marrack P, and Kappler J: The saphylococcal enterotoxins and their relatives. Science 248: 705-711, 1990.
16. Marrack P, Blackman M, Kushnir E, and Kappler J: The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 171: 455-464, 1990.
17. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer H, and Wagner H: T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J Exp Med 175: 91-98, 1992.
18. Pinto M, Torten M, and Birnbaum SC: Suppression of the in vivo humoral and cellular immune response by staphylococcal enterotoxin B. Transplantation 25: 320, 1978.
19. McCormack JE, Kappler J, and Marrack P: Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo. Proc Natl Acad Sci USA 91: 2086-2090, 1994.
20. Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, and Steinman L: Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365: 642-644, 1993.
21. Schiffenbauer J, Johnson HM, Butfiloski EJ, Wegrzyn L, and Soos JM: Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 90: 8543-8546, 1993.
22. Rott O, and Fleischer B: A superantigen as virulence factor in an acute bacterial infection. J Infect Dis 169: 1142-1146, 1994.
23. a expressing cells. Nature 339: 541-544, 1989.
24. Jones L, Chin LA, Merriam GR, Nelson LM, and Kruisbeck AM: Failure of clonal deletion in neonatally thymectomized mice: Tolerance is preserved through anergy. J Exp Med 172: 1277-1285, 1990.
25. + T cells in staphylococcus enterotoxin B-primed mice. J Exp Med 172: 1065-1070, 1990.
26. Webb S, Morris C, and Sprent J: Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 63: 1249-1256, 1990.
27. Luther S, Shakhov AN, Xenarios I, Haga S, Imai S, and Acha-Orbea H: New infectious mammary tumor virus superantigen with Vβ-specificity indentical to staphylococcal enterotoxin B (SEB). Eur J Immunol 25: 1757-1764, 1994.
28. Coffin J: Retroviroidae and their replication. In Virology, 2nd edn, Fields BN (Ed). Raven Press, New York, 1985, pp. 1437-1500.
29. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, and Stevenson M: A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365: 666-669, 1993.
30. Nusse R, and Varmus E: Many tumours induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109, 1982.
31. Peters G, Brookes S, Smith R, and Dickson C: Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell 33: 369-377, 1983.
32. Dickson C, Smith R, Brookes S, and Peters G: Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 37: 529-536, 1984.
33. Bittner JJ: Some possible effects on nursing on the mammary gland tumor incidence in mice. Science 84: 162-169, 1936.
34. Tsubura A, Inaba M, Imai S, Murakami A, Oyaizu N, Yasumizu R, Ohnishi Y, Tanaka H, Morii S, and Ikehara S: Intervention of T-cells in tranportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo. Cancer Res 48: 6555-6559, 1988.
35. Golovkina TV, Chervonsky A, Dudley JP, and Ross SR: Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69: 637-645, 1992.
36. Held W, Waanders GA, Shakhov AN, Scarpellino L, Acha-Orbea H, and MacDonald HR: Super-antigen-induced immune stimulatin amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74: 529-540, 1993.
37. Acha-Orbea H, Shakhov AN, Scapellino L, Kolb E, Müller V, Vessaz-Shaw A, Fuchs R, Blöchlinger K, Rollini P, Billote J, Sarafidou M, MacDonald HR, and Diggelmann H: Clonal deletion of Vβ14 positive T cells in mammary tumor virus transgenic mice. Nature 350: 207-211, 1991.
38. Choi Y, Kappler JW, and Marrack P: A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumor virus. Nature 350: 203-207, 1991.
39. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med 177: 359-367, 1993.
40. a (Mtv-7). J Exp Med 175: 1623-1633, 1992.
41. Held W, Acha-Orbea H, MacDonald HR, and Waanders GA: Superantigens and retroviral infection: insights from mouse mammary tumour virus. Immunol Today 15: 184-190, 1994.
42. Held W, Waanders GA, Acha-Orbea H, and MacDonald HR: Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J Exp Med 180: 2347-2351, 1994.
43. Waanders GA, Shakhov AN, Held W, Karapetian O, Acha-Orbea H, and MacDonald HR: Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J Exp Med 177: 1359-1366, 1993.
44. Karapetian O, Shakhov AN, Kraehenbuhl J-P, and Acha-Orbea H: Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J Exp Med 180: 1511-1516, 1994.
45. Bentvelzen P, and Hilgers J: Murine mammary tumor virus. In Viral Oncology, Klein G (Ed). Raven Press, New York, 1980, pp. 311-355.
46. Festenstein H: Immunogenic and biological aspects of in vitro allotransformation (MLR) in the mouse. Transplant Rev 15: 62-88, 1973.
47. Acha-Orbea H, Mitchell DJ, Timmerman L, Wraith DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, and Steinman L: Limited heterogeneity of T cell receptors in experimental allergic encephalomyelitis. Cell 54: 263-273, 1988.
48. Rott O, Wekerle H, and Fleischer B: Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen. Int Immunol 4: 347-353, 1992.
49. Soos JM, Schiffenbauer J, and Johnson HM: Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J Neuroimmunol 43: 39-43, 1993.
50. Rott O, Mignon GK, Fleischer B, Charrere J, and Cash E: Superantigens induce primary T cell responses to soluble autoantigens by a non-V beta-specific mechanism of bystander activation. Cell Immunol 161: 158-165, 1995.
51. Soos JM, Hobeika AC, Butfiloski EJ, Schiffen- bauer J, and Johnson HM: Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen. Proc Natl Acad Sci USA 92: 6082-6086, 1995.
52. Wooley PH, and Cingel B: Staphylococcal enterotoxin B increases the severity of type II collagen induced arthritis in mice. Ann Rheum Dis 54: 298-304, 1995.
53. Hohlfeld R, Toyka KV, Heininger K, Grosse-Wilde H, and Kalies I: Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 310: 244-246, 1984.
54. He XW, Goronzy J, and Weyand C: Selective induction of rheumatoid factors by superantigens and human helper T cells. J Clin Invest 89: 673-680, 1992.
55. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Finegold D, and Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes mellitus involvement. Nature 371: 351-355, 1994.
56. MacDonald HR, and Acha-Orbea H: Superantigen as suspect. Nature 371: 283-284, 1994.
57. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figueras MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D, et al. Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 153: 1360-1377, 1994.
58. Eisenbarth GS: Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314: 1360-1368, 1986.
59. Heath WR, Allison J, Hoffman MW, Schönrich G, Arnold B, and Miller JFAP: Autoimmunity to extra-thymic antigens as a consequence of local production of interleukin-2. Nature 349: 547-549, 1992.